{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:06:26Z","timestamp":1751364386419,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2020QH1079","2021QH2021"],"award-info":[{"award-number":["2020QH1079","2021QH2021"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U2005204,82000142"],"award-info":[{"award-number":["U2005204,82000142"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2022J01264"],"award-info":[{"award-number":["2022J01264"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint Funds for the innovation of science and Technology, Fujian province","award":["2021Y9086"],"award-info":[{"award-number":["2021Y9086"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00277-024-05692-1","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T03:11:59Z","timestamp":1710385919000},"page":"2393-2404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nomogram predictive models for adult patients with acute lymphoblastic leukaemia based on real-world treatment outcomes"],"prefix":"10.1007","volume":"103","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianda","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"5692_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE et al (2021) Cancer Stat 2021 CA Cancer J Clin 71:7\u201333","journal-title":"Cancer Stat 2021 CA Cancer J Clin"},{"key":"5692_CR2","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.4065\/80.11.1517","volume":"80","author":"EJ Jabbour","year":"2005","unstructured":"Jabbour EJ, Faderl S, Kantarjian HM (2005) Adult acute lymphoblastic leukemia. Mayo Clin Proc 80:1517\u20131527","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"5692_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/cncr.24862","volume":"116","author":"S Faderl","year":"2010","unstructured":"Faderl S, O\u2019Brien S, Pui CH et al (2010) Adult acute lymphoblastic leukemia: concepts and strategies. Cancer 116(5):1165\u20131176","journal-title":"Cancer"},{"issue":"6","key":"5692_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","volume":"27","author":"F Huguet","year":"2009","unstructured":"Huguet F, Leguay T, Raffoux E et al (2009) Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol 27(6):911\u2013918","journal-title":"J Clin Oncol"},{"issue":"3","key":"5692_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2017.265","volume":"32","author":"N Toft","year":"2018","unstructured":"Toft N, Birgens H, Abrahamsson J et al (2018) Results of NOPHO ALL2008 treatment for patients aged 1\u201345 years with acute lymphoblastic leukemia. Leukemia 32(3):606\u2013615","journal-title":"Leukemia"},{"key":"5692_CR6","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3324\/haematol.2016.144311","volume":"101","author":"N Gokbuget","year":"2016","unstructured":"Gokbuget N, Dombret H, Ribera JM et al (2016) International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed\/refractory acute lymphoblastic leukemia. Haematologica 101:1524\u20131533","journal-title":"Haematologica"},{"key":"5692_CR7","first-page":"166","volume":"17","author":"S Paul","year":"2019","unstructured":"Paul S, Rausch C, Nasnas P et al (2019) Treatment of relapsed\/refractory acute lymphoblastic leukemia. Clin Adv Hematol Oncol 17:166\u2013175","journal-title":"Clin Adv Hematol Oncol"},{"issue":"4","key":"5692_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2141.2010.08246.x","volume":"150","author":"JM Rowe","year":"2010","unstructured":"Rowe JM (2010) Prognostic factors in adult acute lymphoblastic leukaemia. Br J Haematol 150(4):389\u2013405","journal-title":"Br J Haematol"},{"issue":"4","key":"5692_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41409-020-01101-z","volume":"56","author":"C Greil","year":"2021","unstructured":"Greil C, Engelhardt M, Ihorst G et al (2021) Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia. Bone Marrow Transpl 56(4):841\u2013852","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"5692_CR10","doi-asserted-by":"publisher","first-page":"101322","DOI":"10.1016\/j.beha.2021.101322","volume":"34","author":"A Bleyer","year":"2021","unstructured":"Bleyer A (2021) Important factors improving outcome of young adults with acute lymphoblastic leukemia (ALL). Best Pract Res Clin Haematol 34(4):101322","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"5692_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3324\/haematol.2018.196055","volume":"104","author":"AL Fedullo","year":"2019","unstructured":"Fedullo AL, Messina M, Elia L et al (2019) Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica 104(2):312\u2013318","journal-title":"Haematologica"},{"issue":"9","key":"5692_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/17474086.2022.2125375","volume":"15","author":"R Ma","year":"2022","unstructured":"Ma R, Liu XT, Chang YJ (2022) Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: current status and future directions mainly focusing on a Chinese perspective. Expert Rev Hematol 15(9):789\u2013803","journal-title":"Expert Rev Hematol"},{"issue":"11","key":"5692_CR13","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.bbmt.2019.08.014","volume":"25","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Advani AS, Bachanova V et al (2019) Hematopoietic cell transplantation in the treatment of adult Acute Lymphoblastic Leukemia: updated 2019 evidence-based review from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transpl 25(11):2113\u20132123","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"5692_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11899-016-0317-2","volume":"11","author":"C Speziali","year":"2016","unstructured":"Speziali C, Paulson K, Seftel M (2016) Hematopoietic cell transplantation for Acute lymphoblastic leukemia in adults. Curr Hematol Malig Rep 11(3):175\u2013184","journal-title":"Curr Hematol Malig Rep"},{"issue":"7","key":"5692_CR15","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"C Rita Alaggio","year":"2022","unstructured":"Rita Alaggio C, Amador I, Anagnostopoulos et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748","journal-title":"Leukemia"},{"issue":"7","key":"5692_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/ajh.25124","volume":"93","author":"L Cui","year":"2018","unstructured":"Cui L, Li Z-G, Chai Y-H et al (2018) Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008: the first nation-wide prospective multicenter study in China. Am J Hematol 93(7):913\u2013920","journal-title":"Am J Hematol"},{"doi-asserted-by":"crossref","unstructured":"Hagop Kantarjian D, Thomas et al (2004) Susan O\u2019Brien,. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. ;101(12):2788\u2009\u2013\u2009801","key":"5692_CR17","DOI":"10.1002\/cncr.20668"},{"key":"5692_CR18","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","volume":"21","author":"BD Cheson","year":"2003","unstructured":"Cheson BD, Bennett JM, Kopecky KJ et al (2003) Revised recommendations of the International Working Group for Diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in Acute myeloid leukemia. J Clin Oncol 21:4642\u20134649","journal-title":"J Clin Oncol"},{"doi-asserted-by":"crossref","unstructured":"Paul S, Kantarjian H, Jabbour EJ et al (2016) Adult Acute Lymphoblastic Leukemia. Mayo Clin Proc. ;91(11):1645\u20131666","key":"5692_CR19","DOI":"10.1016\/j.mayocp.2016.09.010"},{"issue":"1","key":"5692_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.seminhematol.2008.09.003","volume":"46","author":"N G\u00f6kbuget","year":"2009","unstructured":"G\u00f6kbuget N, Hoelzer D (2009) Treatment of adult acute lymphoblastic leukemia. Semin Hematol 46(1):64\u201375","journal-title":"Semin Hematol"},{"issue":"24","key":"5692_CR21","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1200\/JCO.2017.76.8192","volume":"36","author":"F Huguet","year":"2018","unstructured":"Huguet F, Chevret S, Leguay T et al (2018) Intensified therapy of Acute lymphoblastic leukemia in adults: report of the Randomized GRAALL-2005 clinical trial. J Clin Oncol 36(24):2514\u20132523","journal-title":"J Clin Oncol"},{"issue":"4","key":"5692_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.leu.2404598","volume":"21","author":"CH Pui","year":"2007","unstructured":"Pui CH, Campana D (2007) Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia. Leukemia 21(4):593\u2013594","journal-title":"Leukemia"},{"issue":"2","key":"5692_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1200\/JOP.18.00271","volume":"15","author":"I Aldoss","year":"2019","unstructured":"Aldoss I, Forman SJ, Pullarkat V (2019) Acute lymphoblastic leukemia in the older adult. J Oncol Pract 15(2):67\u201375","journal-title":"J Oncol Pract"},{"issue":"5","key":"5692_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.hoc.2009.07.001","volume":"23","author":"K Mr\u00f3zek","year":"2009","unstructured":"Mr\u00f3zek K, Harper DP, Aplan PD (2009) Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am 23(5):991\u20131010","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"5692_CR25","doi-asserted-by":"publisher","first-page":"E147","DOI":"10.1188\/16.CJON.E147-E154","volume":"20","author":"S Jacobson","year":"2016","unstructured":"Jacobson S, Tedder M, Eggert J (2016) Adult Acute Lymphoblastic Leukemia: a genetic overview and application to clinical practice. Clin J Oncol Nurs 20(6):E147\u2013E154","journal-title":"Clin J Oncol Nurs"},{"issue":"10","key":"5692_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/17474086.2018.1509702","volume":"11","author":"NA Horowitz","year":"2018","unstructured":"Horowitz NA, Akasha D, Rowe JM (2018) Advances in the genetics of acute lymphoblastic leukemia in adults and the potential clinical implications. Expert Rev Hematol 11(10):781\u2013791","journal-title":"Expert Rev Hematol"},{"doi-asserted-by":"crossref","unstructured":"Burmeister T, Schwartz S, Bartram CR, et al. Patients\u2019 age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group. Blood 2008;112(3):918\u20139","key":"5692_CR27","DOI":"10.1182\/blood-2008-04-149286"},{"issue":"25","key":"5692_CR28","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMra2113347","volume":"386","author":"R Fo\u00e0","year":"2022","unstructured":"Fo\u00e0 R, Chiaretti S (2022) Philadelphia chromosome-positive Acute Lymphoblastic Leukemia. N Engl J Med 386(25):2399\u20132411","journal-title":"N Engl J Med"},{"issue":"12","key":"5692_CR29","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1016\/S2352-3026(18)30176-5","volume":"5","author":"E Jabbour","year":"2018","unstructured":"Jabbour E, Short NJ, Ravandi F et al (2018) Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study. Lancet Haematol 5(12):e618\u2013e627","journal-title":"Lancet Haematol"},{"issue":"1","key":"5692_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-023-01409-5","volume":"16","author":"E Jabbour","year":"2023","unstructured":"Jabbour E, Short NJ, Jain N et al (2023) The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades. J Hematol Oncol 16(1):22","journal-title":"J Hematol Oncol"},{"issue":"S1","key":"5692_CR31","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.5045\/br.2020.S006","volume":"55","author":"HS Park","year":"2020","unstructured":"Park HS (2020) Current treatment strategies for Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Blood Res 55(S1):S32\u2013S36","journal-title":"Blood Res"},{"issue":"4","key":"5692_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11912-018-0679-9","volume":"20","author":"C Bourlon","year":"2018","unstructured":"Bourlon C, Lacayo-Le\u00f1ero D et al (2018) Hematopoietic stem cell transplantation for adult Philadelphia-negative Acute Lymphoblastic Leukemia in the First Complete Remission in the era of minimal residual disease. Curr Oncol Rep 20(4):36","journal-title":"Curr Oncol Rep"},{"issue":"12","key":"5692_CR33","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1080\/10428194.2021.1933475","volume":"62","author":"S Khazal","year":"2021","unstructured":"Khazal S, Kebriaei P et al (2021) Hematopoietic cell transplantation for acute lymphoblastic leukemia: review of current indications and outcomes. Leuk Lymphoma 62(12):2831\u20132844","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"5692_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/j.seminhematol.2020.06.003","volume":"57","author":"J Bartram","year":"2020","unstructured":"Bartram J, Patel B, Fielding AK (2020) Monitoring MRD in ALL: methodologies, technical aspects and optimal time points for measurement. Semin Hematol 57(3):142\u2013148","journal-title":"Semin Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05692-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:04:04Z","timestamp":1720109044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05692-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5692"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05692-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"(<b>Approval of the research by an Institutional Reviewer Board<\/b>: The clinical study was approved by the Institutional Reviewer Board of the Fujian Medical University Union Hospital (Ethical Approval Number: 2023KJCX090).)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the Registration No. Of the study\/trial"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"All authors have read the journal\u2019s policy on disclosure of potential conflict of interest and have none to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}